| scholarly article | Q13442814 |
| P50 | author | Vehary Sakanyan | Q55965493 |
| P2093 | author name string | Lynn A Megeney | |
| Laurence Dubreil | |||
| Karl Rouger | |||
| Mireille Ledevin | |||
| Yan Cherel | |||
| Marie-Claire Arnaud | |||
| Laetitia Guevel | |||
| Marie Feron | |||
| P2860 | cites work | Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members | Q24290252 |
| Some protein tyrosine phosphatases target in part to lipid rafts and interact with caveolin-1 | Q24304322 | ||
| Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy | Q24307833 | ||
| The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate | Q24317714 | ||
| Signaling by target of rapamycin proteins in cell growth control | Q24522447 | ||
| Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B | Q27860731 | ||
| TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling | Q28131740 | ||
| Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases | Q28187456 | ||
| Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo | Q28206290 | ||
| Skeletal muscle hypertrophy and atrophy signaling pathways | Q28266345 | ||
| Caveolin-3 in muscular dystrophy | Q28267179 | ||
| Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy | Q28267252 | ||
| Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate | Q28280837 | ||
| Glycoprotein complex anchoring dystrophin to sarcolemma | Q28292439 | ||
| Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix | Q28296676 | ||
| SH3 domain-mediated interaction of dystroglycan and Grb2 | Q28301162 | ||
| Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins | Q28585091 | ||
| X chromosome-linked muscular dystrophy (mdx) in the mouse | Q28589078 | ||
| Loss of dystrophin causes aberrant mechanotransduction in skeletal muscle fibers | Q28593090 | ||
| Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha | Q28616168 | ||
| Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome | Q29615538 | ||
| Dystrophin: the protein product of the Duchenne muscular dystrophy locus | Q29618077 | ||
| Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals | Q30050310 | ||
| Regulation of protein kinase cascades by protein phosphatase 2A. | Q33632946 | ||
| Caveolae and caveolin-3 in muscular dystrophy | Q33845396 | ||
| Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene | Q34190227 | ||
| Tumor suppressor PTEN acts through dynamic interaction with the plasma membrane | Q34574432 | ||
| Regulation of PTEN function as a PIP3 gatekeeper through membrane interaction | Q36544446 | ||
| PTEN: a new guardian of the genome. | Q37270432 | ||
| Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy | Q37574344 | ||
| Association of the polymorphisms in the 5′‐untranslated region of PTEN gene with type 2 diabetes in a Japanese population | Q40615998 | ||
| GSK-3beta negatively regulates skeletal myotube hypertrophy | Q40719828 | ||
| Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. | Q40767544 | ||
| Rapamycin-induced inhibition of the 70-kilodalton S6 protein kinase | Q41608842 | ||
| Freeze-fracture studies of muscle caveolae in human muscular dystrophy. | Q41879930 | ||
| Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice | Q42052137 | ||
| Hypertrophic response of Duchenne and limb-girdle muscular dystrophies is associated with activation of Akt pathway | Q44610584 | ||
| Altered activity of signaling pathways in diaphragm and tibialis anterior muscle of dystrophic mice. | Q44915435 | ||
| Glucocorticoid treatment alleviates dystrophic myofiber pathology by activation of the calcineurin/NF-AT pathway. | Q45084815 | ||
| Regulation of phosphatidylinositol 3-kinase (PI3K)/Akt and nuclear factor-kappa B signaling pathways in dystrophin-deficient skeletal muscle in response to mechanical stretch. | Q46452445 | ||
| Caveolin-3 is not an integral component of the dystrophin glycoprotein complex | Q48025640 | ||
| Association of the dystroglycan complex isolated from bovine brain synaptosomes with proteins involved in signal transduction | Q48251106 | ||
| Canine X-linked muscular dystrophy. An animal model of Duchenne muscular dystrophy: clinical studies. | Q50892927 | ||
| Muscular dystrophy in the mdx mouse: histopathology of the soleus and extensor digitorum longus muscles. | Q52255659 | ||
| Association of dystrophin and an integral membrane glycoprotein. | Q52485843 | ||
| The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs | Q59051983 | ||
| Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle | Q59089242 | ||
| An error in dystrophin mRNA processing in golden retriever muscular dystrophy, an animal homologue of Duchenne muscular dystrophy | Q59416437 | ||
| Activation of JNK1 contributes to dystrophic muscle pathogenesis | Q64379561 | ||
| Calmodulin specifically binds three proteins of the dystrophin-glycoprotein complex | Q68164364 | ||
| The mutant mdx: inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates | Q68984568 | ||
| The mdx mouse skeletal muscle myopathy: I. A histological, morphometric and biochemical investigation | Q70054992 | ||
| Increased number of caveolae and caveolin-3 overexpression in Duchenne muscular dystrophy | Q78109530 | ||
| Up-regulation of mitogen activated protein kinases in mdx skeletal muscle following chronic treadmill exercise | Q81837319 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1459-1470 | |
| P577 | publication date | 2009-03-05 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | PTEN contributes to profound PI3K/Akt signaling pathway deregulation in dystrophin-deficient dog muscle | |
| P478 | volume | 174 |
| Q33523810 | A duchenne muscular dystrophy gene hot spot mutation in dystrophin-deficient cavalier king charles spaniels is amenable to exon 51 skipping |
| Q40746398 | A quantum leap in the reproducibility, precision, and sensitivity of gene expression profile analysis even when sample size is extremely small |
| Q42639922 | Activation of AKT signaling promotes cell growth and survival in α7β1 integrin-mediated alleviation of muscular dystrophy |
| Q56770399 | Altered mitogen-activated protein kinase signaling in dystrophic (mdx) muscle |
| Q49846340 | Deregulation of Nrf2/ARE signaling pathway causes susceptibility of dystrophin-deficient myotubes to menadione-induced oxidative stress |
| Q34222153 | Dietary blue pigments derived from genipin, attenuate inflammation by inhibiting LPS-induced iNOS and COX-2 expression via the NF-κB inactivation. |
| Q27309883 | Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation |
| Q30512833 | Enhancing muscle membrane repair by gene delivery of MG53 ameliorates muscular dystrophy and heart failure in δ-Sarcoglycan-deficient hamsters. |
| Q98166029 | GSK3 inhibition with low dose lithium supplementation augments murine muscle fatigue resistance and specific force production |
| Q42493873 | Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival. |
| Q33685967 | MicroRNA-486-dependent modulation of DOCK3/PTEN/AKT signaling pathways improves muscular dystrophy-associated symptoms |
| Q38444259 | NF-κB inhibition reveals a novel role for HGF during skeletal muscle repair |
| Q100696231 | PTEN Inhibition Ameliorates Muscle Degeneration and Improves Muscle Function in a Mouse Model of Duchenne Muscular Dystrophy |
| Q34152280 | Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials |
| Q30557792 | Reduced IGF signaling prevents muscle cell death in a Caenorhabditis elegans model of muscular dystrophy |
| Q35282588 | Regulation of DMD pathology by an ankyrin-encoded miRNA. |
| Q45781418 | Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy |
| Q92874029 | The Dog Model in the Spotlight: Legacy of a Trustful Cooperation |
| Q35768547 | The anti-inflammatory activities of ethanol extract from Dan-Lou prescription in vivo and in vitro |
| Q39755104 | microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network |
Search more.